320 related articles for article (PubMed ID: 30006780)
1. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
2. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
3. Interictal amylin levels in chronic migraine patients: A case-control study.
Irimia P; Martínez-Valbuena I; Mínguez-Olaondo A; Domínguez-Vivero C; Sánchez-Arias JA; Martínez-Vila E; Luquin MR; Leira R
Cephalalgia; 2021 Apr; 41(5):604-612. PubMed ID: 33269952
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
Ramón C; Cernuda-Morollón E; Pascual J
Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
[TBL] [Abstract][Full Text] [Related]
5. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
6. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.
Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M
J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657
[TBL] [Abstract][Full Text] [Related]
7. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
8. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
10. Circulating nociceptin and CGRP in medication-overuse headache.
Munksgaard SB; Ertsey C; Frandsen E; Bendtsen L; Tekes K; Jensen RH
Acta Neurol Scand; 2019 Mar; 139(3):269-275. PubMed ID: 30457160
[TBL] [Abstract][Full Text] [Related]
11. [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide].
Garcia-Estevez DA; Pardo-Parrado M; Silvarrey-Rodriguez S
Rev Neurol; 2017 Aug; 65(4):153-156. PubMed ID: 28726232
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.
Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K
Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
14. CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
Domínguez C; Vieites-Prado A; Pérez-Mato M; Sobrino T; Rodríguez-Osorio X; López A; Campos F; Martínez F; Castillo J; Leira R
Headache; 2018 Jan; 58(1):78-87. PubMed ID: 29131327
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Schifter S; Jansen-Olesen I; Olesen J
Neurology; 2000 Nov; 55(9):1335-40. PubMed ID: 11087777
[TBL] [Abstract][Full Text] [Related]
16. Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients.
Fekrazad R; Sardarian A; Azma K; Karami M; Borhani-Haghighi A; Gharesi-Fard B; Movahedi B
Neurol Sci; 2018 Jul; 39(7):1217-1223. PubMed ID: 29654418
[TBL] [Abstract][Full Text] [Related]
17. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine.
Cernuda-Morollón E; Ramón C; Martínez-Camblor P; Serrano-Pertierra E; Larrosa D; Pascual J
Pain; 2015 May; 156(5):820-824. PubMed ID: 25735000
[TBL] [Abstract][Full Text] [Related]
18. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
[TBL] [Abstract][Full Text] [Related]
19. Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period.
Gupta R; Ahmed T; Banerjee B; Bhatia M
J Headache Pain; 2009 Jun; 10(3):161-6. PubMed ID: 19277835
[TBL] [Abstract][Full Text] [Related]
20. Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks.
Alpuente A; Gallardo VJ; Asskour L; Caronna E; Torres-Ferrus M; Pozo-Rosich P
Cephalalgia; 2022 Mar; 42(3):186-196. PubMed ID: 34601944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
